Acurx Pharmaceuticals Stock (NASDAQ: ACXP) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 4.739K / 177.723K |
Day Range | - - - |
52 Wk Range | 1.170 - 8.820 |
Market Cap | $35.611M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 2.26% |
Days to Cover | 2.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Acurx Pharmaceuticals (NASDAQ: ACXP) through any online brokerage.
Other companies in Acurx Pharmaceuticals’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Cellectar Biosciences (NASDAQ:CLRB), Sensei Biotherapeutics (NASDAQ:SNSE) and Viracta Therapeutics (NASDAQ:VIRX).
The latest price target for Acurx Pharmaceuticals (NASDAQ: ACXP) was reported by HC Wainwright & Co. on Tuesday, March 19, 2024. The analyst firm set a price target for 12.00 expecting ACXP to rise to within 12 months (a possible 430.97% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Acurx Pharmaceuticals (NASDAQ: ACXP) is $2.26 last updated Today at March 28, 2024 at 8:33 AM EDT.
There are no upcoming dividends for Acurx Pharmaceuticals.
Acurx Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Acurx Pharmaceuticals.
Acurx Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.